NASDAQ:DNLI Denali Therapeutics Q1 2025 Earnings Results & Report $18.00 -0.08 (-0.44%) Closing price 04:00 PM EasternExtended Trading$18.00 0.00 (0.00%) As of 04:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Denali Therapeutics missed analyst earnings expectations in its Q1 2025 results, released May 6, 2025. The company reported EPS of -$0.78 versus the -$0.71 consensus estimate. Research:ProfileEarnings HistoryForecast Earnings Announcement Details QuarterQ1 2025Report DateMay 6, 2025TimeBefore Market OpensConference Call4:00 PM ET Denali Therapeutics EPS ResultsActual EPS-$0.78Consensus EPS -$0.71Beat/MissMissed by -$0.07One Year Ago EPS-$0.68EPS Beat Rate6 of last 8 quartersDenali Therapeutics Revenue ResultsActual RevenueN/AExpected Revenue$3.24 millionBeat/MissN/AYoY Revenue GrowthN/AConference Call ResourcesPress Release (8-K)Quarterly Report (10-Q)Earnings HistoryCompany ProfilePowered by Earnings DocumentsPress Release(8-K)Quarterly report(10-Q) Denali Therapeutics Q1 2025 Earnings FAQ Did Denali Therapeutics beat earnings estimates for Q1 2025? Denali Therapeutics (NASDAQ:DNLI) reported earnings of -$0.78 per share for Q1 2025, missing the consensus estimate of -$0.71. The report was announced on Tuesday, May 6, 2025. Denali Therapeutics Earnings HeadlinesTranscript : Denali Therapeutics Inc. Presents at UBS Global Biopharma Conference 2026, Nov-17-2026 02:40 PM3 hours ago | marketscreener.comMDenali Therapeutics Inc. (NASDAQ:DNLI) Stock Has Consensus Target Price of $35.71November 16 at 2:28 AM | americanbankingnews.comYou missed yesterday's deadline…In June 2025, a drilling crew near the Grand Canyon uncovered an energy source producing nearly eight times the output of Saudi Arabia's largest oil well, enough potential energy to power civilization for two million years. While the One Big Beautiful Bill Act stripped tax credits from solar, wind, and EVs on July 4th, this discovery was reclassified alongside oil and nuclear and secured eight years of credits. Google signed a 15-year contract, and Bill Gates committed 100 million dollars.November 17 at 1:00 AM | Behind the Markets (Ad)Denali Therapeutics (NASDAQ:DNLI) Research Coverage Started at Wells Fargo & CompanyNovember 16 at 1:36 AM | americanbankingnews.comTranscript : Denali Therapeutics Inc. Presents at Stifel 2026 Healthcare Conference 2026, Nov-11-2026 09:20 AMNovember 14 at 8:11 AM | marketscreener.comMDenali Therapeutics Inc. (DNLI) Presents at Stifel 2026 Healthcare Conference 2026 TranscriptNovember 13, 2026 | seekingalpha.comSee More Denali Therapeutics Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Denali Therapeutics? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Denali Therapeutics and other key companies, straight to your email. Email Address About Denali TherapeuticsDenali Therapeutics (NASDAQ:DNLI) is a biotechnology company focused on developing medicines for neurodegenerative diseases and other disorders involving the nervous system. Founded in 2015, the company is headquartered in South San Francisco, California. Its research and development programs target conditions including Alzheimer’s disease, Parkinson’s disease, amyotrophic lateral sclerosis and lysosomal storage disorders. Denali’s portfolio includes investigational drug candidates that aim to address underlying disease processes, as well as its TransportVehicle platform, designed to help therapeutic molecules cross the blood-brain barrier. Denali was co-founded by Ryan Watts, who serves as the company’s chief executive officer. Its medicines remain in development, and the company’s work includes research and clinical testing of potential treatments for patients with neurological conditions.View Denali Therapeutics ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Amazon’s Black Friday Rush Could Kick Off a Holiday Season That Defines Its YearThe Next Nuclear Opportunity May Be in Fuel, Not Reactors: 3 Stocks to WatchTyson Foods' Earnings Beat Hides a Warning for Consumer Staples Dividend InvestorsMongoDB's Biggest Advantage May Be GitLab's Biggest WeaknessMicrosoft's Outage Barely Moved Its Stock, But a Bigger Risk May Be BuildingTyson Foods' 10% Surge Puts a Breakout in Sight, But Wall Street Remains CautiousOndas Is Building a Defense Growth Engine, But Can It Deliver on Its Backlog? Upcoming Earnings Lowe's Companies (11/18/2026)TJX Companies (11/18/2026)Target (11/18/2026)Palo Alto Networks (11/18/2026)NetEase (11/19/2026)Alibaba Group (11/19/2026)PDD (11/19/2026)Ross Stores (11/19/2026)Walmart (11/19/2026)Intuit (11/19/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.